cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.5697157
title: First extinct representative of the rove beetle subtribe Acylophorina from Baltic amber, and its phylogenetic placement

description: The recently established subtribe Acylophorina comprises several morphologically diverse genera. They were revealed as a monophyletic group primarily by molecular-based phylogenetic analysis. The morphological disparity and significantly disjunct geographical distribution of Acylophorina suggest a higher diversity in the past that has been reduced by extinctions. Consequently, the fossil record preserving extinct transitional morphologies is a very important source of data to test for monophyly and improve overall phylogenetic understanding of this subtribe. Here, we describe the first undoubted representative of the subtribe as a new species, <i>Acylophorus hoffeinsorum</i> sp. nov., and confirm its placement within Acylophorina by phylogenetic analysis using Bayesian inference and maximum parsimony methods. We question the monophyly of <i>Acylophorus</i> Nordmann, 1837, the most speciose genus in the subtribe, and call for further phylogenetic investigation and taxonomic revision of this genus and the subtribe as a whole. Additionally, we argue that the extinct Cenozoic <i>Acylophorus immotus</i> Scudder, 1900, which so far has been erroneously known as the only fossil member of Acylophorina, in fact belongs to the subfamily Tachyporinae. http://zoobank.org/urn:lsid:zoobank.org:pub:D14B76FC-E0E5-4BC6-BDCE-3D577891C55D
DOI: 10.6084/m9.figshare.5697157.v1
title: First extinct representative of the rove beetle subtribe Acylophorina from Baltic amber, and its phylogenetic placement

description: The recently established subtribe Acylophorina comprises several morphologically diverse genera. They were revealed as a monophyletic group primarily by molecular-based phylogenetic analysis. The morphological disparity and significantly disjunct geographical distribution of Acylophorina suggest a higher diversity in the past that has been reduced by extinctions. Consequently, the fossil record preserving extinct transitional morphologies is a very important source of data to test for monophyly and improve overall phylogenetic understanding of this subtribe. Here, we describe the first undoubted representative of the subtribe as a new species, <i>Acylophorus hoffeinsorum</i> sp. nov., and confirm its placement within Acylophorina by phylogenetic analysis using Bayesian inference and maximum parsimony methods. We question the monophyly of <i>Acylophorus</i> Nordmann, 1837, the most speciose genus in the subtribe, and call for further phylogenetic investigation and taxonomic revision of this genus and the subtribe as a whole. Additionally, we argue that the extinct Cenozoic <i>Acylophorus immotus</i> Scudder, 1900, which so far has been erroneously known as the only fossil member of Acylophorina, in fact belongs to the subfamily Tachyporinae. http://zoobank.org/urn:lsid:zoobank.org:pub:D14B76FC-E0E5-4BC6-BDCE-3D577891C55D
DOI: 10.6084/m9.figshare.5697142
title: Additional file 4: Table S2. of Genes for asparagine metabolism in Lotus japonicus: differential expression and interconnection with photorespiration

description: List and description of the L. japonicus transcriptomic data analyzed in the present work. All transcriptomic data are available online in the Arrayexpress database. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.5697142.v1
title: Additional file 4: Table S2. of Genes for asparagine metabolism in Lotus japonicus: differential expression and interconnection with photorespiration

description: List and description of the L. japonicus transcriptomic data analyzed in the present work. All transcriptomic data are available online in the Arrayexpress database. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.5697115
title: Additional file 1: of Phylogenetic relationships of cone snails endemic to Cabo Verde based on mitochondrial genomes

description: Maps showing sampling localities; diversity of Kalloconus radular teeth. (ZIP 3996Â kb)
DOI: 10.6084/m9.figshare.5697115.v1
title: Additional file 1: of Phylogenetic relationships of cone snails endemic to Cabo Verde based on mitochondrial genomes

description: Maps showing sampling localities; diversity of Kalloconus radular teeth. (ZIP 3996Â kb)
DOI: 10.6084/m9.figshare.5697079
title: Example LAMMPS Input File from A nanoscale perspective on the effects of transverse microprestress on drying creep of nanoporous solids

description: A LAMMPS input (text) file providing an example of our simulation setup and methodology for simulating drying creep behavior under transverse stress
DOI: 10.6084/m9.figshare.5697079.v1
title: Example LAMMPS Input File from A nanoscale perspective on the effects of transverse microprestress on drying creep of nanoporous solids

description: A LAMMPS input (text) file providing an example of our simulation setup and methodology for simulating drying creep behavior under transverse stress
DOI: 10.6084/m9.figshare.5697076
title: Simulation Output from A nanoscale perspective on the effects of transverse microprestress on drying creep of nanoporous solids

description: A compressed collection of output data files used in our analysis of drying creep
DOI: 10.6084/m9.figshare.5697076.v1
title: Simulation Output from A nanoscale perspective on the effects of transverse microprestress on drying creep of nanoporous solids

description: A compressed collection of output data files used in our analysis of drying creep
DOI: 10.6084/m9.figshare.5697064
title: Viannia paper (Coughlan et al 2017) Suppl Tables

description: Viannia paper (Coughlan et al 2017) Suppl Tables
DOI: 10.6084/m9.figshare.5697058
title: Evaluation of anionic surfactant removal by anaerobic degradation of commercial laundry wastewater and domestic sewage

description: An expanded granular sludge bed reactor was evaluated for the anaerobic digestion of commercial laundry wastewater and domestic sewage focused on the removal of linear alkylbenzene sulfonate (LAS). The reactor was operated in three stages, all under mesophilic conditions and with a hydraulic retention time of 36 h. At stage I, the laundry wastewater was diluted with tap water (influent: 15.3 ± 4.9 mg LAS/L); at stage II, 50% of the feed volume was domestic sewage and 50% was a mixture of tap water and laundry wastewater (influent: 15.8 ± 4.9 mg LAS/L); and at stage III, only domestic sewage was used as a diluent of the laundry wastewater (influent: 24.1 ± 4.1 mg LAS/L). Due to the addition of domestic sewage the organic compounds content and LAS in the influent increased. Under such conditions, it was observed that LAS removal rate decreased from 77.2 ± 14.9% (stage I) to 55.3 ± 18.4% (stage III). Statistical tests indicated that the decrease of the LAS removal rate was significant and indicated a correlation between the removal of LAS and specific organic loading rate. The analysis of 16S rRNA gene sequencing revealed genera similar to <i>Geobacter, Desulfovibrio, Syntrophomonas, Syntrophus, Desulfobulbus, Desulfomonile</i>, and <i>Desulfomicrobium</i>, which were related to the degradation of LAS.
DOI: 10.6084/m9.figshare.5697058.v1
title: Evaluation of anionic surfactant removal by anaerobic degradation of commercial laundry wastewater and domestic sewage

description: An expanded granular sludge bed reactor was evaluated for the anaerobic digestion of commercial laundry wastewater and domestic sewage focused on the removal of linear alkylbenzene sulfonate (LAS). The reactor was operated in three stages, all under mesophilic conditions and with a hydraulic retention time of 36 h. At stage I, the laundry wastewater was diluted with tap water (influent: 15.3 ± 4.9 mg LAS/L); at stage II, 50% of the feed volume was domestic sewage and 50% was a mixture of tap water and laundry wastewater (influent: 15.8 ± 4.9 mg LAS/L); and at stage III, only domestic sewage was used as a diluent of the laundry wastewater (influent: 24.1 ± 4.1 mg LAS/L). Due to the addition of domestic sewage the organic compounds content and LAS in the influent increased. Under such conditions, it was observed that LAS removal rate decreased from 77.2 ± 14.9% (stage I) to 55.3 ± 18.4% (stage III). Statistical tests indicated that the decrease of the LAS removal rate was significant and indicated a correlation between the removal of LAS and specific organic loading rate. The analysis of 16S rRNA gene sequencing revealed genera similar to <i>Geobacter, Desulfovibrio, Syntrophomonas, Syntrophus, Desulfobulbus, Desulfomonile</i>, and <i>Desulfomicrobium</i>, which were related to the degradation of LAS.
DOI: 10.21942/uva.5697034.v1
title: Seating capacity cinemas EU West 1955

description: This spreadsheet contains data on the number of cinema seats per inhabitant of 26 (Western) European countries in 1955, taken from the following report: UNESCO, Statistics on film and cinema 1955-1975, 1981: pp. 67-70.
DOI: 10.6084/m9.figshare.5697031
title: Velocity measurements in a model of a coronary bifurcation with stent. Numerical benchmark (Database) BIO-17-1458

description: Experimental measurements for several stenting techniques under steady and unsteady flow conditions were performed. The test conditions were highly controlled and uncertainty was accurately predicted. The results obtained in this research consist of readily accessible, easy to emulate, detailed velocity fields and geometry.<br>This dataset is explained and commented in:Carrascal, P. G., García, J. G., Pallares, J. S., Ruiz, F. C., & Martín, F. M. (2018). Benchmark for numerical models of stented coronary bifurcation flow. <i>Journal of biomechanical engineering</i>, <i>140</i>(9), 091009.<br>
DOI: 10.6084/m9.figshare.5697031.v2
title: Velocity measurements in a model of a coronary bifurcation with stent. Numerical benchmark (Database) BIO-17-1458

description: Experimental measurements for several stenting techniques under steady and unsteady flow conditions were performed. The test conditions were highly controlled and uncertainty was accurately predicted. The results obtained in this research consist of readily accessible, easy to emulate, detailed velocity fields and geometry.<br>This dataset is explained and commented in:Carrascal, P. G., García, J. G., Pallares, J. S., Ruiz, F. C., & Martín, F. M. (2018). Benchmark for numerical models of stented coronary bifurcation flow. <i>Journal of biomechanical engineering</i>, <i>140</i>(9), 091009.<br>
DOI: 10.6084/m9.figshare.5697031.v1
title: Velocity measurements in a model of a coronary bifurcation with stent. Numerical benchmark (Database) BIO-17-1458

description: Experimental measurements for several stenting techniques under steady and unsteady flow conditions were performed. The test conditions were highly controlled and uncertainty was accurately predicted. The results obtained in this research consist of readily accessible, easy to emulate, detailed velocity fields and geometry
DOI: 10.6084/m9.figshare.5696959
title: Supplementary Material for: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

description: <b><i>Background:</i></b> People with diabetes and kidney disease have a high risk of cardiovascular events and progression of kidney disease. Sodium glucose co-transporter 2 inhibitors lower plasma glucose by reducing the uptake of filtered glucose in the kidney tubule, leading to increased urinary glucose excretion. They have been repeatedly shown to induce modest natriuresis and reduce HbA1c, blood pressure, weight, and albuminuria in patients with type 2 diabetes. However, the effects of these agents on kidney and cardiovascular events have not been extensively studied in patients with type 2 diabetes and established kidney disease. <b><i>Methods:</i></b> The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial aims to compare the efficacy and safety of canagliflozin ­versus placebo at preventing clinically important kidney and cardiovascular outcomes in patients with diabetes and established kidney disease. CREDENCE is a randomized, double-blind, event-driven, placebo-controlled trial set in in 34 countries with a projected duration of ∼5.5 years and enrolling 4,401 adults with type 2 diabetes, estimated glomerular filtration rate ≥30 to &lt;90 mL/min/1.73 m<sup>2</sup>, and albuminuria (urinary albumin:creatinine ratio &gt;300 to ≤5,000 mg/g). The study has 90% power to detect a 20% reduction in the risk of the primary outcome (α = 0.05), the composite of end-stage kidney disease, doubling of serum creatinine, and renal or cardiovascular death. <b><i>Conclusion:</i></b> CREDENCE will provide definitive evidence about the effects of canagliflozin on renal (and cardiovascular) outcomes in patients with type 2 diabetes and established kidney disease. <b><i>Trial Registration:</i></b> EudraCT number: 2013-004494-28; ClinicalTrials.gov identifier: NCT02065791.
DOI: 10.6084/m9.figshare.5696959.v1
title: Supplementary Material for: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

description: <b><i>Background:</i></b> People with diabetes and kidney disease have a high risk of cardiovascular events and progression of kidney disease. Sodium glucose co-transporter 2 inhibitors lower plasma glucose by reducing the uptake of filtered glucose in the kidney tubule, leading to increased urinary glucose excretion. They have been repeatedly shown to induce modest natriuresis and reduce HbA1c, blood pressure, weight, and albuminuria in patients with type 2 diabetes. However, the effects of these agents on kidney and cardiovascular events have not been extensively studied in patients with type 2 diabetes and established kidney disease. <b><i>Methods:</i></b> The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial aims to compare the efficacy and safety of canagliflozin ­versus placebo at preventing clinically important kidney and cardiovascular outcomes in patients with diabetes and established kidney disease. CREDENCE is a randomized, double-blind, event-driven, placebo-controlled trial set in in 34 countries with a projected duration of ∼5.5 years and enrolling 4,401 adults with type 2 diabetes, estimated glomerular filtration rate ≥30 to &lt;90 mL/min/1.73 m<sup>2</sup>, and albuminuria (urinary albumin:creatinine ratio &gt;300 to ≤5,000 mg/g). The study has 90% power to detect a 20% reduction in the risk of the primary outcome (α = 0.05), the composite of end-stage kidney disease, doubling of serum creatinine, and renal or cardiovascular death. <b><i>Conclusion:</i></b> CREDENCE will provide definitive evidence about the effects of canagliflozin on renal (and cardiovascular) outcomes in patients with type 2 diabetes and established kidney disease. <b><i>Trial Registration:</i></b> EudraCT number: 2013-004494-28; ClinicalTrials.gov identifier: NCT02065791.
DOI: 10.6084/m9.figshare.5696956
title: MOESM9 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 9. NNK fibroblasts.
DOI: 10.6084/m9.figshare.5696956.v1
title: MOESM9 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 9. NNK fibroblasts.
DOI: 10.6084/m9.figshare.5696950
title: MOESM8 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 8. WM9 subclones.
DOI: 10.6084/m9.figshare.5696950.v1
title: MOESM8 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 8. WM9 subclones.
DOI: 10.6084/m9.figshare.5696944
title: MOESM7 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 7. SHG quantification.
DOI: 10.6084/m9.figshare.5696932
title: MOESM5 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 5. F-actin quantification.
DOI: 10.6084/m9.figshare.5696932.v1
title: MOESM5 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 5. F-actin quantification.
DOI: 10.6084/m9.figshare.5696926
title: MOESM4 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 4. BLCA CPCR mut counts.
DOI: 10.6084/m9.figshare.5696926.v1
title: MOESM4 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 4. BLCA CPCR mut counts.
DOI: 10.6084/m9.figshare.5696920
title: MOESM3 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 3. BLCA2 mut counts.
DOI: 10.6084/m9.figshare.5696920.v1
title: MOESM3 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 3. BLCA2 mut counts.
DOI: 10.6084/m9.figshare.5696914
title: MOESM2 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 2. BLCA1 mut counts.
DOI: 10.6084/m9.figshare.5696914.v1
title: MOESM2 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 2. BLCA1 mut counts.
DOI: 10.6084/m9.figshare.5696893
title: MOESM12 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 12. Raji B-cell phalloidin.
DOI: 10.6084/m9.figshare.5696893.v1
title: MOESM12 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 12. Raji B-cell phalloidin.
DOI: 10.6084/m9.figshare.5696878
title: MOESM11 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 11. Smoking LUAD.
DOI: 10.6084/m9.figshare.5696878.v1
title: MOESM11 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 11. Smoking LUAD.
DOI: 10.6084/m9.figshare.5696863
title: MOESM10 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 10. Perimeter area ratios.
DOI: 10.6084/m9.figshare.5696863.v1
title: MOESM10 of The human, F-actin-based cytoskeleton as a mutagen sensor

description: Additional file 10. Perimeter area ratios.
DOI: 10.6084/m9.figshare.5696839
title: Additional file 9: Table S6. of De novo transcriptome assembly from flower buds of dioecious, gynomonoecious and chemically masculinized female Coccinia grandis reveals genes associated with sex expression and modification

description: Gene ontology (GO) enrichment analysis for differentially expressed transcripts in each pairwise comparison. (XLSX 1509 kb)
DOI: 10.6084/m9.figshare.5696839.v1
title: Additional file 9: Table S6. of De novo transcriptome assembly from flower buds of dioecious, gynomonoecious and chemically masculinized female Coccinia grandis reveals genes associated with sex expression and modification

description: Gene ontology (GO) enrichment analysis for differentially expressed transcripts in each pairwise comparison. (XLSX 1509 kb)
DOI: 10.6084/m9.figshare.5696821
title: Additional file 8: Table S5. of De novo transcriptome assembly from flower buds of dioecious, gynomonoecious and chemically masculinized female Coccinia grandis reveals genes associated with sex expression and modification

description: Expression matrix of transcripts with P-values at most 1e-3 and at least 2^2 fold differential expression. (XLS 7379 kb)
DOI: 10.6084/m9.figshare.5696821.v1
title: Additional file 8: Table S5. of De novo transcriptome assembly from flower buds of dioecious, gynomonoecious and chemically masculinized female Coccinia grandis reveals genes associated with sex expression and modification

description: Expression matrix of transcripts with P-values at most 1e-3 and at least 2^2 fold differential expression. (XLS 7379 kb)
DOI: 10.6084/m9.figshare.5696779
title: Additional file 3: Table S2. of Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis

description: The league table of the network for the adverse effects estimates the treatments according to their relative effects. (XLSX 12Â kb)
DOI: 10.6084/m9.figshare.5696779.v1
title: Additional file 3: Table S2. of Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis

description: The league table of the network for the adverse effects estimates the treatments according to their relative effects. (XLSX 12Â kb)
DOI: 10.6084/m9.figshare.5696770
title: Additional file 6: Table S4. of De novo transcriptome assembly from flower buds of dioecious, gynomonoecious and chemically masculinized female Coccinia grandis reveals genes associated with sex expression and modification

description: Annotation report for the de novo-assembled C. grandis flower bud transcriptome generated using Trinotate. Available at https://doi.org/10.6084/m9.figshare.5217652.v1 . (XLSX 5870 kb)
DOI: 10.6084/m9.figshare.5696770.v1
title: Additional file 6: Table S4. of De novo transcriptome assembly from flower buds of dioecious, gynomonoecious and chemically masculinized female Coccinia grandis reveals genes associated with sex expression and modification

description: Annotation report for the de novo-assembled C. grandis flower bud transcriptome generated using Trinotate. Available at https://doi.org/10.6084/m9.figshare.5217652.v1 . (XLSX 5870 kb)
DOI: 10.6084/m9.figshare.5696764
title: Additional file 2: Table S1. of Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis

description: The league table of the network for the estimation of clinical cure rates of the treatments according to their relative effects. (XLSX 12Â kb)
DOI: 10.6084/m9.figshare.5696764.v1
title: Additional file 2: Table S1. of Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis

description: The league table of the network for the estimation of clinical cure rates of the treatments according to their relative effects. (XLSX 12Â kb)
DOI: 10.6084/m9.figshare.5696722
title: MOESM1 of Overview of Akatsuki data products: definition of data levels, method and accuracy of geometric correction

description: Additional file 1. List of files used for accuracy estimation of pointing correction. List of image files used for calculating parameters $$\bar{a}, \hat{a} {\text{ and }}\sigma$$ a ÂŻ , a ^ and Ď . This is also used for roughly estimating $$\theta_{1} {\text{ and }}\theta_{2}$$ Î¸ 1 and Î¸ 2 . Names of the files displayed in this Additional file 1 may not be exactly identical to those stored in the publication sites, where the data files are released to the public. However, users can find the file uniquely because the observation date is included in each file name.
DOI: 10.6084/m9.figshare.5696722.v1
title: MOESM1 of Overview of Akatsuki data products: definition of data levels, method and accuracy of geometric correction

description: Additional file 1. List of files used for accuracy estimation of pointing correction. List of image files used for calculating parameters $$\bar{a}, \hat{a} {\text{ and }}\sigma$$ a ÂŻ , a ^ and Ď . This is also used for roughly estimating $$\theta_{1} {\text{ and }}\theta_{2}$$ Î¸ 1 and Î¸ 2 . Names of the files displayed in this Additional file 1 may not be exactly identical to those stored in the publication sites, where the data files are released to the public. However, users can find the file uniquely because the observation date is included in each file name.
DOI: 10.6084/m9.figshare.5696710
title: Additional file 8: Table S5. of Phosphoproteomics reveals network rewiring to a pro-adhesion state in annexin-1-deficient mammary epithelial cells

description: Cellular component enrichment of ANXA1-modulated phosphoproteins. (XLSX 10 kb)
DOI: 10.6084/m9.figshare.5696710.v1
title: Additional file 8: Table S5. of Phosphoproteomics reveals network rewiring to a pro-adhesion state in annexin-1-deficient mammary epithelial cells

description: Cellular component enrichment of ANXA1-modulated phosphoproteins. (XLSX 10 kb)